Reaction
Xerosis reporting signals
As of the last recalculation, Xerosis appears in 1,208 FAERS reports alongside 28 co-occurring drug terms. The strongest observed disproportionality signal is ISOTRETINOIN (PRR 164.4).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Isotretinoin | 340 | 164.4 | 165.6 |
| Panitumumab | 76 | 89.1 | 89.6 |
| Erlotinib | 21 | 38.0 | 38.1 |
| Erlotinib Hydrochloride | 25 | 35.1 | 35.2 |
| Tretinoin | 13 | 27.9 | 27.9 |
| Ketoconazole Foam | 20 | 23.7 | 23.7 |
| Ketoconazole Cream, 2% | 20 | 23.6 | 23.6 |
| Terbinafine Hydrochloride | 12 | 23.5 | 23.5 |
| Ketoconazole | 21 | 21.3 | 21.3 |
| Vemurafenib | 14 | 20.3 | 20.3 |
| Gefitinib | 10 | 19.2 | 19.3 |
| Clobetasol Propionate Ointment Usp, 0.05% | 10 | 16.9 | 16.9 |
| Clobetasol Propionate | 10 | 16.8 | 16.8 |
| Iron Sucrose | 8 | 14.5 | 14.6 |
| Trametinib | 20 | 14.5 | 14.5 |
| Triamcinolone Acetonide Ointment Usp, 0.05% | 19 | 14.2 | 14.2 |
| Abacavir Sulfate | 7 | 12.4 | 12.5 |
| Minocycline | 8 | 11.9 | 11.9 |
| Triamcinolone Acetonide | 19 | 10.7 | 10.8 |
| Cetuximab | 19 | 10.6 | 10.6 |
| Fluorouracil Cream, 0.5% | 40 | 9.3 | 9.3 |
| Regorafenib | 6 | 8.9 | 8.9 |
| Fluorouracil | 39 | 8.9 | 8.9 |
| Oxaliplatin | 35 | 8.3 | 8.3 |
| Dabrafenib | 10 | 8.2 | 8.2 |
| Secukinumab | 66 | 7.4 | 7.4 |
| Osimertinib | 8 | 4.3 | 4.3 |
| Adapalene | 3 | 0.3 | 0.3 |